Participation bias assessment in a community-based study of myocardial infarction, 2002-2005

Mayo Clinic Proceedings

Volumn 82, Issue 8, 2007, Pages 933-938

  Gerber, Yariv ^a,b   Jacobsen, Steven J ^a   Killian, Jill M ^a   Weston, Susan A ^a   Roger, Veronique L ^a  

^a MAYO CLINIC   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC LUNG DISEASE; CLINICAL FEATURE; COMMUNITY CARE; COMORBIDITY; CREATININE CLEARANCE; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PERIPHERAL VASCULAR DISEASE;

EID: 34547615013     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.8.933     Document Type: Article

References (38)

1. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1998:115-134.
2. Olson SH, Voigt LF, Begg CB, Weiss NS. Reporting participation in case-control studies. Epidemiology. 2002;13:123-126.
3. Sandler DP. On revealing what we'd rather hide: the problem of describing study participation [editorial]. Epidemiology. 2002;13:117.
4. Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ. 2004 Oct 16;329:883-887. Epub 2004 Oct 6.
5. Greenland S. Response and follow-up bias in cohort studies. Am J Epidemiol. 1977;106:184-187.
6. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006 Feb 1;163:197-203. Epub 2005 Dec 7.
7. Adams MM, Scherr PA, Branch LG, et al. A comparison of elderly participants in a community survey with nonparticipants. Public Health Rep. 1990;105:617-622.
8. Jousilahti P, Salomaa V, Kuulasmaa K, Niemela M, Vartiainen E. Total and cause specific mortality among participants and non-participants of population based health surveys: a comprehensive follow up of 54 372 Finnish men and women. J Epidemiol Community Health. 2005;59:310-315.
9. Jacobsen SJ, Mahoney DW, Redfield MM, Bailey KR, Burnett JC Jr, Rodeheffer RJ. Participation bias in a population-based echocardiography study. Ann Epidemiol. 2004;14:579-584.
10. Ramos E, Lopes C, Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol. 2004;14:437-441.
11. Jacomb PA, Jorm AF, Korten AE, Christensen H, Henderson AS. Predictors of refusal to participate: a longitudinal health survey of the elderly in Australia. BMC Public Health. 2002;2:4-9. Epub 2002 Mar 13.
12. Vestbo J, Rasmussen FV. Baseline characteristics are not sufficient indicators of non-response bias follow up studies. J Epidemiol Community Health. 1992;46:617-619.
13. Boshuizen HC, Viet AL, Picavet HS, Botterweck A, van Loon AJ. Non-response in a survey of cardiovascular risk factors in the Dutch population: determinants and resulting biases. Public Health. 2006 Apr;120:297-308. Epub 2005 Dec 20.
14. Criqui MH, Barrett-Connor E, Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol. 1978;108:367-372.
15. Eagan TM, Eide GE, Gulsvik A, Bakke PS. Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations. J Clin Epidemiol. 2002;55:775-781.
16. Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol. 1999;9:188-195.
17. Kurland LT, Elveback LR, Nobrega FT. Population studies in Rochester and Olmsted County, Minnesota, 1900-1968. In: Kessler I, Levin ML, eds. The Community as an Epidemiologic Laboratory: A Casebook of Community Studies. Baltimore, MD: Johns Hopkins University Press; 1970:47-70.
18. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
19. Roger VL, Killian JM, Weston SA, et al. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation. 2006 Aug 22;114:790-797. Epub 2006 Aug 14.
20. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J. 2002;144:981-986.
21. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003 Nov 18;108:2543-2549. Epub 2003 Nov 10.
22. Roger VL, Killian J, Henkel M, et al. Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol. 2002;55:593-601.
23. Doll R, Hill AB. Mortality in relation to smoking: ten years' observations of British doctors. Br Med J. 1964;1:1399-1410.
24. Gordon T, Moore FE, Shurtleff D, Dawber TR. Some methodologic problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J Chronic Dis. 1959;10:186-206.
25. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham offspring study. Am J Epidemiol. 1979;110:281-290.
26. Luepker RV, Arnett DK, Jacobs DR Jr, et al. Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med. 2006;119:42-49.
27. Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;151:468-477.
28. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-2216.
29. Burke JP, Rhodes T, Jacobson DJ, et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol. 2006 Jul 1;164:41-46. Epub 2006 Apr 12.
30. Delgado-Aros S, Locke GR III, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99:1801-1806.
31. Rule AD, Rodeheffer RJ, Larson TS, et al. Limitations of estimating glomerular filtration rate from serum creatinine in the general population [published correction appears in Mayo Clin Proc. 2006;81:1639]. Mayo Clin Proc. 2006;81:1427-1434.
32. Benfante R, Reed D, MacLean C, Kagan A. Response bias in the Honolulu Heart Program. Am J Epidemiol. 1989;130:1088-1100.
33. Pirzada A, Yan LL, Garside DB, Schiffer L, Dyer AR, Daviglus ML. Response rates to a questionnaire 26 years after baseline examination with minimal interim participant contact and baseline differences between respondents and nonrespondents. Am J Epidemiol. 2004;159:94-101.
34. Bisgard KM, Folsom AR, Hong CP, Sellers TA. Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. Am J Epidemiol. 1994;139:990-1000.
35. Moorman PG, Skinner CS, Evans JP, et al. Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2004;13:1349-1354.
36. Jha P, Deboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol. 1996;27:1335-1342.
37. Corbie-Smith G, Thomas SB, St George DM. Distrust, race, and research. Arch Intern Med. 2002;162:2458-2463.
38. Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996;88:630-634.